Glynn Faircloth

3.7k total citations
71 papers, 3.1k citations indexed

About

Glynn Faircloth is a scholar working on Molecular Biology, Cancer Research and Biotechnology. According to data from OpenAlex, Glynn Faircloth has authored 71 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 32 papers in Cancer Research and 25 papers in Biotechnology. Recurrent topics in Glynn Faircloth's work include Synthesis and Biological Activity (28 papers), Marine Sponges and Natural Products (23 papers) and Microbial Natural Products and Biosynthesis (19 papers). Glynn Faircloth is often cited by papers focused on Synthesis and Biological Activity (28 papers), Marine Sponges and Natural Products (23 papers) and Microbial Natural Products and Biosynthesis (19 papers). Glynn Faircloth collaborates with scholars based in Spain, Italy and United States. Glynn Faircloth's co-authors include Maurizio D’Incalci, José Jimeno, Eugenio Erba, Giovanna Damia, Daniele Bergamaschi, Sergio Marchini, Massimo Broggini, Raffaella Giavazzi, Shengkan Jin and Kathleen W. Scotto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Endocrinology.

In The Last Decade

Glynn Faircloth

70 papers receiving 3.0k citations

Peers

Countries citing papers authored by Glynn Faircloth

Since Specialization

Citations

This map shows the geographic impact of Glynn Faircloth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glynn Faircloth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glynn Faircloth more than expected).

Fields of papers citing papers by Glynn Faircloth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glynn Faircloth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glynn Faircloth. The network helps show where Glynn Faircloth may publish in the future.

Co-authorship network of co-authors of Glynn Faircloth

This figure shows the co-authorship network connecting the top 25 collaborators of Glynn Faircloth. A scholar is included among the top collaborators of Glynn Faircloth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glynn Faircloth. Glynn Faircloth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Activity of pm02734 against human breast and prostate tumors 2006 ·Cancer Research ·Mariano J. Elices, Doreen LePage, Wendy Grant, Enrique Álvarez, María José Guillén, Carmen Cuevas, (unknown), Glynn Faircloth	3
2	Toxicokinetic evaluation of a novel anti-tumor agent, Zalypsis® (PM00104), in dogs 2006 ·Cancer Research ·(unknown), Pablo Avilés, Teresa L. Wright, María José Guillén, (unknown), (unknown), Simon Munt, Carmen Cuevas, Glynn Faircloth	2
3	The marine sphingolipid-derived compound ES 285 triggers an atypical cell death pathway 2006 ·APOPTOSIS ·María Teresa Salcedo, (unknown), (unknown), Gabriel Otero, Glynn Faircloth, J.M. Fernández-Sousa, Jesús Ávila, Francisco Wandosell	53
4	Quantitative analysis of Variolin analog (PM01218) in mouse and rat plasma by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry 2006 ·Journal of Chromatography B ·Junfa Yin, Pablo Avilés, (unknown), Wang‐Tso Lee, María José Guillén, Simon Munt, (unknown), Glynn Faircloth	6
5	Induction of resistance to Aplidin® in a human ovarian cancer cell line related to MDR expression 2005 ·Cancer Biology & Therapy ·Gianluca Tognon, Sergio Bernasconi, Nicola Celli, Glynn Faircloth, Carmen Cuevas, José Jimeno, Eugenio Erba, Maurizio D’Incalci	6
6	Molecular characterisation of two human cancer cell lines selected in vitro for their chemotherapeutic drug resistance to ET-743 2004 ·European Journal of Cancer ·Sergio Marchini, (unknown), Riccardo Bonomi, Giovanna Chiorino, (unknown), Lawrence Weissbach, Francis J. Hornicek, Massimo Broggini, Glynn Faircloth, Maurizio D’Incalci	20
7	Fetal bovine serum, but not human serum, inhibits the in vitro cytotoxicity of ET-743 (Yondelis, trabectedin) 2003 ·Cancer Chemotherapy and Pharmacology ·Gianluca Tognon, Roberta Frapolli, (unknown), Eugenio Erba, Massimo Zucchetti, Glynn Faircloth, Maurizio D’Incalci	11
8	Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies 2003 ·Cancer Chemotherapy and Pharmacology ·Riccardo Riccardi, Daniela Meco, Tina Colombo, Paolo Ubezio, Massimo Zucchetti, (unknown), (unknown), Glynn Faircloth, (unknown), Maurizio D’Incalci	62
9	Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of Aplidin®, a novel marine‐derived antineoplastic agent, in human plasma 2003 ·Rapid Communications in Mass Spectrometry ·(unknown), Pablo Avilés, William Lee, (unknown), (unknown), (unknown), Glynn Faircloth	10
10	Dexamethasone potentiates the activity of ecteinascidin 743 in pre-clinical melanoma and osteosarcoma models 2002 ·Glynn Faircloth, Wendy Grant, Jaime Jimeno, (unknown)	2
11	Preclinical toxicity studies of kahalalide F, a new anticancer agent: single and multiple dosing regimens in the rat 2002 ·Cancer Chemotherapy and Pharmacology ·Alan Brown, (unknown), Glynn Faircloth, Barry H. Levine	23
12	Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways 2001 ·International Journal of Cancer ·Giovanna Damia, (unknown), Laura Carrassa, (unknown), Glynn Faircloth, Giordano Liberi, Marco Foiani, Maurizio D’Incalci	136
13	Evaluation of the use of in vitro methodologies as tools for screening new compounds for potential in vivo toxicity 2001 ·Toxicology in Vitro ·Judith Luber‐Narod, Barry L. Smith, Wayne Grant, José Jimeno, Luis López Lázaro, Glynn Faircloth	12
14	Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action 2001 ·European Journal of Cancer ·Eugenio Erba, Daniele Bergamaschi, (unknown), Giovanna Damia, Simona Ronzoni, Glynn Faircloth, Maurizio D’Incalci	229
15	True 2000 ·British Journal of Cancer ·(unknown), (unknown), (unknown), Sara Vignati, Ivan Muradore, Maurizio D’Incalci, Daniele Bergamaschi, (unknown), Glynn Faircloth, José Jimeno	31
16	Effect of ecteinascidin-743 on the interaction between DNA binding proteins and DNA. 1999 ·PubMed ·Marina Bonfanti, (unknown), José Faro, Glynn Faircloth, Giuseppina Caretti, Roberto Mantovani, Maurizio D’Incalci	70
17	Bioanalysis of aplidine, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography after derivatization with trans-4′-hydrazino-2-stilbazole 1999 ·Journal of Chromatography B Biomedical Sciences and Applications ·Rolf W. Sparidans, (unknown), Olaf van Tellingen, (unknown), R.E.C. Henrar, José Jimeno, Glynn Faircloth, (unknown), Kenneth L. Rinehart, Jos H. Beijnen	16
18	Quantitative determination of Ecteinascidin 743 in human plasma by miniaturized high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry 1998 ·Journal of Mass Spectrometry ·Hilde Rosing, M. J. X. Hillebrand, José Jimeno, (unknown), (unknown), Glynn Faircloth, R.E.C. Henrar, J. B. Vermorken, Esteban Cvitkovic, A. Bult, Jos H. Beijnen	46
19	In vitro antitumor activity of the novel marine agent, Ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients 1998 ·Annals of Oncology ·Elżbieta Izbicka, R. A. Lawrence, Éric Raymond, Gail Eckhardt, Glynn Faircloth, José Jimeno, Gary M. Clark, (unknown)	122
20	In vitro schedule-dependency of myelotoxicity and cytotoxicity of Ecteinascidin 743 (ET-743) 1998 ·Annals of Oncology ·Michele Ghielmini, (unknown), Eugenio Erba, Daniele Bergamaschi, S. Pampallona, José Jimeno, Glynn Faircloth, Cristiana Sessa	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact